John G Ullman & Associates Inc Baxter International Inc Transaction History

John G Ullman & Associates Inc

$649 Million
Q3 2024

A detailed history of John G Ullman & Associates Inc transactions in Baxter International Inc stock. As of the latest transaction made, John G Ullman & Associates Inc holds 39,979 shares of BAX stock, worth $1.31 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

39,979

Previous 41,179 2.91%

Holding current value

$1.31 Million

Previous $1.38 Million 10.24%

% of portfolio

0.23%

Previous 0.22%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$32.85 - $40.26 $39,420 - $48,312	-1,200 Reduced 2.91%	39,979 $1.52 Million
Q2 2024 Aug 08, 2024	SELL	$32.87 - $43.55 $720,773 - $954,964	-21,928 Reduced 34.75%	41,179 $1.38 Million
Q1 2024 May 06, 2024	BUY	$37.88 - $43.77 $337,132 - $389,553	8,900 Added 16.42%	63,107 $2.7 Million
Q4 2023 Jan 31, 2024	SELL	$31.71 - $38.95 $495,373 - $608,476	-15,622 Reduced 22.37%	54,207 $2.1 Million
Q3 2023 Nov 01, 2023	SELL	$37.32 - $49.29 $119,013 - $157,185	-3,189 Reduced 4.37%	69,829 $2.64 Million
Q2 2023 Aug 21, 2023	BUY	$39.98 - $47.68 $393,163 - $468,885	9,834 Added 15.56%	73,018 $3.33 Million
Q1 2023 May 05, 2023	BUY	$37.58 - $52.57 $1.35 Million - $1.89 Million	36,000 Added 132.43%	63,184 $2.56 Million
Q4 2022 Feb 08, 2023	SELL	$49.7 - $57.71 $1.97 Million - $2.28 Million	-39,550 Reduced 59.27%	27,184 $1.39 Million
Q3 2022 Oct 19, 2022	BUY	$53.86 - $66.8 $89,246 - $110,687	1,657 Added 2.55%	66,734 $3.59 Million
Q2 2022 Jul 27, 2022	BUY	$63.83 - $80.0 $2.57 Million - $3.22 Million	40,278 Added 162.42%	65,077 $4.18 Million
Q1 2022 Apr 29, 2022	SELL	$76.85 - $89.45 $9,836 - $11,449	-128 Reduced 0.51%	24,799 $1.92 Million
Q4 2021 Jan 26, 2022	BUY	$74.57 - $87.19 $242,352 - $283,367	3,250 Added 14.99%	24,927 $2.14 Million
Q3 2021 Nov 02, 2021	BUY	$73.77 - $83.61 $521,332 - $590,871	7,067 Added 48.37%	21,677 $1.74 Million
Q2 2021 Jul 23, 2021	SELL	$80.5 - $88.01 $28,738 - $31,419	-357 Reduced 2.39%	14,610 $1.18 Million
Q1 2021 Apr 22, 2021	SELL	$76.38 - $86.03 $15,276 - $17,206	-200 Reduced 1.32%	14,967 $1.26 Million
Q4 2020 Feb 05, 2021	SELL	$75.39 - $82.36 $30,005 - $32,779	-398 Reduced 2.56%	15,167 $1.22 Million
Q3 2020 Nov 06, 2020	SELL	$78.33 - $90.73 $23,499 - $27,219	-300 Reduced 1.89%	15,565 $1.25 Million
Q1 2020 Apr 14, 2020	SELL	$71.57 - $93.3 $347,901 - $453,531	-4,861 Reduced 23.45%	15,865 $1.29 Million
Q4 2019 Jan 29, 2020	SELL	$76.7 - $88.45 $65,195 - $75,182	-850 Reduced 3.94%	20,726 $1.73 Million
Q3 2019 Oct 21, 2019	SELL	$81.4 - $89.78 $2.76 Million - $3.04 Million	-33,850 Reduced 61.07%	21,576 $1.89 Million
Q2 2019 Aug 02, 2019	SELL	$73.44 - $82.41 $22,032 - $24,723	-300 Reduced 0.54%	55,426 $4.54 Million
Q1 2019 Apr 30, 2019	SELL	$64.48 - $81.31 $52,099 - $65,698	-808 Reduced 1.43%	55,726 $4.53 Million
Q4 2018 Jan 29, 2019	SELL	$61.45 - $77.8 $76,013 - $96,238	-1,237 Reduced 2.14%	56,534 $3.72 Million
Q3 2018 Nov 02, 2018	SELL	$70.71 - $77.75 $14,141 - $15,550	-200 Reduced 0.35%	57,771 $4.45 Million
Q2 2018 Jul 23, 2018	SELL	$63.43 - $75.41 $210,714 - $250,512	-3,322 Reduced 5.42%	57,971 $4.28 Million
Q1 2018 Apr 19, 2018	SELL	$62.56 - $72.26 $956,167 - $1.1 Million	-15,284 Reduced 19.96%	61,293 $3.99 Million
Q4 2017 Jan 31, 2018	SELL	$61.45 - $66.05 $1.38 Million - $1.48 Million	-22,431 Reduced 22.66%	76,577 $4.95 Million
Q3 2017 Nov 03, 2017	BUY	$59.5 - $64.61 $5.89 Million - $6.4 Million	99,008	99,008 $6.21 Million

Others Institutions Holding BAX

# of Institutions

1,008

Shares Held

451M

Call Options Held

2.79M

Put Options Held

2.44M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $16.6B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.

Account

John G Ullman & Associates Inc Baxter International Inc Transaction History